AI Terminal
Transgene
Capital/Financing Update • Jul 6, 2021
1715_rns_2021-07-06_7512561b-981a-47c0-bd39-1c0941a43bed.pdf
Capital/Financing Update
Open in ViewerOpens in native device viewer
PRESS RELEASE
Balance sheet of the liquidity contract with Natixis Oddo BHF SCA as of June 30, 2021
Strasbourg, July 06, 2021 – 06:00 pm CET
Under the liquidity contract entrusted by Transgene to Natixis Oddo BHF SCA, as of June 30, 2021, the following resources were managed through the liquidity account:
- 175,000 shares
- € 312,618.00
In the first half of 2021, a total of:
| Purchases | 528,545 shares |
€ 1,354,956 | 998 market transactions |
|---|---|---|---|
| Sales | 548,545 shares |
€ 1,389,681 | 1,212 market transactions |
It is recalled that when the liquidity program was initially established in 2016, the following resources were made available:
Cash balance of the liquidity contract: € 500,000.00
At the time the liquidity program was transferred to Natixis Oddo BHF SCA on January 2, 2020, the resources managed through the liquidity account consisted of:
- 164,183 shares
- € 246,158.00
Contacts
Transgene:
Lucie Larguier Director Corporate Communications & IR +33 (0)3 88 27 91 04 [email protected]